Recursion Pharmaceuticals (RXRX) ended the recent trading session at $8.19, demonstrating a -1.92% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 0.08%. Meanwhile, the Dow experienced a drop of 0.12%, and the technology-dominated Nasdaq saw an increase of 0.07%. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.56 per share and revenue of $47.44 million, indicating changes of +1.27% and +6.43%, respectively, compared ...